These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 25313856)

  • 21. Comparison of antimüllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis patients at individual fertility clinics in two multicenter trials.
    Nelson SM; Klein BM; Arce JC
    Fertil Steril; 2015 Apr; 103(4):923-930.e1. PubMed ID: 25624196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients.
    Arce JC; La Marca A; Mirner Klein B; Nyboe Andersen A; Fleming R
    Fertil Steril; 2013 May; 99(6):1644-53. PubMed ID: 23394782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship Between Anti-Müllerian Hormone and
    Sun XY; Lan YZ; Liu S; Long XP; Mao XG; Liu L
    Front Endocrinol (Lausanne); 2020; 11():595448. PubMed ID: 33343511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-Müllerian hormone is correlated with cumulative live birth in minimal ovarian stimulation with clomiphene citrate: a retrospective cohort study.
    Ezoe K; Ni X; Kobayashi T; Kato K
    BMC Pregnancy Childbirth; 2020 Nov; 20(1):740. PubMed ID: 33246461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does the anti-Müllerian hormone truly reflect ovarian response in women with endometrioma?
    Inal ZO; Engin Ustun Y; Yilmaz N; Aktulay A; Bardakci Y; Gulerman C
    J Obstet Gynaecol; 2019 May; 39(4):516-521. PubMed ID: 30744464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential response of AMH to GnRH agonist among individuals: the effect on ovarian stimulation outcomes.
    Cai J; Liu L; Zheng J; Zhang L; Jiang X; Li P; Sha A; Ren J
    J Assist Reprod Genet; 2018 Mar; 35(3):467-473. PubMed ID: 29264688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effectiveness and safety of in vitro maturation of oocytes versus in vitro fertilization in women with a high antral follicle count.
    Ho VNA; Braam SC; Pham TD; Mol BW; Vuong LN
    Hum Reprod; 2019 Jun; 34(6):1055-1064. PubMed ID: 31111879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
    Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
    Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diminished ovarian reserve associates with pregnancy and birth outcomes after IVF: a retrospective cohort study.
    Can S; Yang X; He Y; Wang C; Zou H; Fan Q; Xu X; Cai G; Yunxia C; Xiaoqing P
    Hum Fertil (Camb); 2024 Dec; 27(1):2414813. PubMed ID: 39402927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-Müllerian hormone (AMH) is a strong predictor of live birth in women undergoing assisted reproductive technology.
    Lukaszuk K; Liss J; Kunicki M; Jakiel G; Wasniewski T; Woclawek-Potocka I; Pastuszek E
    Reprod Biol; 2014 Sep; 14(3):176-81. PubMed ID: 25152514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antral follicle count and anti-Müllerian hormone to classify low-prognosis women under the POSEIDON criteria: a classification agreement study of over 9000 patients.
    Esteves SC; Yarali H; Vuong LN; Carvalho JF; Özbek İY; Polat M; Le HL; Pham TD; Ho TM
    Hum Reprod; 2021 May; 36(6):1530-1541. PubMed ID: 33822057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparing the intercycle variation of serum anti-Mullerian hormone and antral follicle count measurements over four consecutive menstrual cycles.
    Wong E; Ng EHY; Li RHW; Ko JKY
    Clin Endocrinol (Oxf); 2023 Mar; 98(3):394-399. PubMed ID: 36325996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ovarian response prediction in GnRH antagonist treatment for IVF using anti-Müllerian hormone.
    Hamdine O; Eijkemans MJ; Lentjes EW; Torrance HL; Macklon NS; Fauser BC; Broekmans FJ
    Hum Reprod; 2015 Jan; 30(1):170-8. PubMed ID: 25355590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Ovarian Reserve Tests and Age in the Prediction of Poor Ovarian Response to Controlled Ovarian Stimulation-A Real-World Data Analysis of 89,002 Patients.
    Wang X; Jin L; Mao YD; Shi JZ; Huang R; Jiang YN; Zhang CL; Liang XY
    Front Endocrinol (Lausanne); 2021; 12():702061. PubMed ID: 34526967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes of anti-Müllerian hormone-tailored ovarian stimulation protocols in in vitro fertilization/intracytoplasmic sperm injection cycles in women of advanced age.
    Liao CC; Lee RK; Lin SY; Lin MH; Hwu YM
    Taiwan J Obstet Gynecol; 2016 Apr; 55(2):239-43. PubMed ID: 27125408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of Cumulative Live Birth Rates Between GnRH-A and PPOS in Low-Prognosis Patients According to POSEIDON Criteria: A Cohort Study.
    Zhang S; Yin Y; Li Q; Zhang C
    Front Endocrinol (Lausanne); 2021; 12():644456. PubMed ID: 34234739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum antimüllerian hormone measurements with second generation assay at two distinct menstrual cycle phases for prediction of cycle cancellation, pregnancy and live birth after in vitro fertilization.
    Rezende CP; Rocha AL; Dela Cruz C; Borges LE; Del Puerto HL; Reis FM
    J Assist Reprod Genet; 2014 Oct; 31(10):1303-10. PubMed ID: 25015034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of cumulative outcomes and influencing factors of patients with discrepancies between age and AMH levels in the early follicular phase prolonged protocol.
    Wang K; Guan Y; Zhang Y; Jia R; Wu S; Yao Z; Zhang M; Li Z
    Front Endocrinol (Lausanne); 2023; 14():1098131. PubMed ID: 36967754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Which is more predictive ovarian sensitivity marker if there is discordance between serum anti-Müllerian hormone levels and antral follicle count? A retrospective analysis.
    Aslan K; Kasapoglu I; Cakir C; Koc M; Celenk MD; Ata B; Avci B; Uncu G
    J Obstet Gynaecol; 2022 Jul; 42(5):1461-1466. PubMed ID: 34996328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retrospective study of ovarian reaction and fertility in women with discordant antimullerian hormone and follicle-stimulating hormone/luteinizing hormone ratios during in vitro fertilization.
    Wang J; Lv Y; Wang X; Zhu G; Zhao F
    J Obstet Gynaecol Res; 2023 Mar; 49(3):966-972. PubMed ID: 36734373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.